Kit Check, the market leader in software solutions for item-level visibility in the pharmaceutical space, announced…
Category: Health care @IT
Antengene to Present at the 40th Annual J.P. Morgan Healthcare Conference
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing…
Photocure to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Photocure ASA (OSE: PHO): The Bladder Cancer Company focused on delivering transformative solutions to improve the…
Dynacure Receives Fast Track Designation for DYN101, an Investigational Antisense Oligonucleotide for the Treatment of Myotubular and Centronuclear Myopathies
Dynacure, a clinical stage biotechnology company focusing on Myotubular and Centronuclear Myopathies (CNM), a group of…
Enveric Biosciences to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022
Enveric Biosciences(NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing next-generation mental health and oncology…
Digital Diagnostics Provides New Designation to Top Executives
Digital Diagnostics recently announced the designation of Co-Founder to the company’s CEO and President/COO, John Bertrand and Seth Rainford,…
New HARMONY Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL) Research Results from HARMONY to facilitate tailored treatment choices in subtypes of blood cancer
Big Data analyses have produced novel insights that may improve the prognostication of patients with AML…
AstraZeneca Levant recognized among the top workplaces in pharma for 2021
AstraZeneca Levant https://edenred.ae/, an affiliate of the multinational pharmaceutical and biotechnology company, has been recently recognized as one…
Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for Pirtobrutinib at the American Society of Hematology Annual Meeting
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today…
BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca’s portfolio
Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated…